Optimization of Sampling and Processing of Samples for Molecular Microbial Research on Ocular Surface Samples
NCT04193774 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2022-07-22
Summary
The use of anesthetics and the processing of the retrieved samples are major confounding factors that influence the results of microbiome research.
Conditions
- Microbiota
- Ocular Surface
Interventions
- DIAGNOSTIC_TEST
-
Conjunctival swab
Swab of the conjunctival fornices of both eyes
- DRUG
-
Oxybuprocaine Hydrochloride 0.4% Eye Drops
One drop of topical anesthesia in one eye
- DRUG
-
artificial tears
One drop of artificial tears in the other eye
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Heleen Delbeke, MD · Universitaire Ziekenhuizen KU Leuven
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-08-19
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Concentration of Ofloxacin Into the Aqueous Humour of Patients With Dry Eye Disease
NCT05213156 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.
NCT02770729 ·Status: TERMINATED ·Phase: PHASE3
-
Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis
NCT02595359 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
NCT02951351 ·Status: COMPLETED ·Phase: NA
-
Cross-Over Evaluation of Two Lubricating Eye Drops
NCT00493662 ·Status: COMPLETED ·Phase: PHASE4
-
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain
NCT06637527 ·Status: TERMINATED ·Phase: PHASE2
-
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
NCT00630019 ·Status: COMPLETED ·Phase: PHASE4
-
Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs
NCT00392275 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms
NCT02028754 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
NCT01193127 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
NCT02756624 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing Preoperative Disinfection of Eyes
NCT04745663 ·Status: TERMINATED ·Phase: PHASE4
-
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
NCT00520260 ·Status: COMPLETED ·Phase: PHASE4
-
Dropless vs. Standard Drops Contralateral Eye Study
NCT02515045 ·Status: COMPLETED ·Phase: PHASE4
-
Intracameral Antibiotic Safety Study
NCT02590523 ·Status: SUSPENDED ·Phase: PHASE3
-
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT01367249 ·Status: COMPLETED ·Phase: PHASE3
-
Antibiotic Resistance In Eye Surgeries
NCT04750655 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT00853970 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery
NCT00136344 ·Status: COMPLETED ·Phase: NA
-
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
NCT00333918 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population
NCT05926258 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
NCT03244072 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
NCT00469690 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Ophthalmic Antiseptic Preparations
NCT05974124 ·Status: COMPLETED ·Phase: NA
-
Surveillance of Ocular Surface Flora (SURFACE)
NCT00621933 ·Status: COMPLETED